The growth of the global hepatitis testing market is being driven by factors like the high burden of hepatitis, increasing blood transfusion and donations, benefits of POC instruments and kits, and awareness initiatives on liver disease.
High cost of macromolecule tests, lack of mandates for nucleic acid tests in developing countries and unfavourable reimbursement scenarios are expected to restrain hepatitis market growth. rising markets, rising technological advancements in molecular diagnostics, and growth within the biotechnology and biopharmaceutical industries are expected to offer strong growth opportunities for players within the market.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Disease Type, Technology, End User and Region |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Bio-Rad Laboratories, Inc., Danaher Corporation, QIAGEN, bioMérieux SA, DiaSorin S.P.A., Ortho Clinical Diagnostics, MedMira Inc., Fujirebio US, Inc., Grifols, S.A. |
The covid-19 Impact on Hepatitis Testing Market:
Like several different industries, COVID-19 badly knocked the electronic and semiconductor trade. This new event has compact nearly 230 countries in exactly a couple of weeks, leading to the forced conclusion of producing and transportation activities at intervals and across the countries. This has directly affected the expansion of the sector. It's calculable that COVID-19 to depart over USD thirty billion impacts on the physics and semiconductor trade. The arena is majorly affected thanks to transport restrictions on major physics and semiconductor staple suppliers. However, the rising want for semiconductors in many industries can supply fast market recovery over the longer-term amount.
Hepatitis Testing Market Segment Overview
By Disease Type, Hepatitis B segment is anticipated to dominate the market throughout the forecast amount.
Based on technology, the hepatitis testing market is segmented into enzyme-linked immunosorbent assay (ELISA), fast diagnostic tests, nucleic acid chain reaction (PCR), isothermal supermolecule amplification technology (INAAT), and other technologies (such as sequencing, mass spectroscopy, and western blotting). The spectrometry segment accounted for the largest share of the hepatitis testing market in 2020.
Based on user, the hospital & diagnostic laboratories phase accounted for the largest share of the hepatitis testing market.
Market Analysis, Insights and Forecast – By Disease Type
· Hepatitis B
· Hepatitis C
· Other Hepatitis
Market Analysis, Insights and Forecast – By Technology
· ELISA
· RDT
· PCR
· INAAT
Market Analysis, Insights and Forecast – By End User
· Hospitals
· Diagnostic Laboratories
· Blood Banks
Hepatitis Testing Market Regional Overview
Region-wise, in terms of regions, North America dominates the global market, and this trend is predicted to continue throughout the forecast period. the large share and high growth of this region may be attributed to the rising prevalence of hepatitis and increased research and clinical trials for hepatitis testing within the US.
However, the Asia Pacific market is estimated to grow at the highest CAGR throughout the forecast period. High burden of hepatitis infections, rising disposable income levels, improving healthcare infrastructure, and increasing awareness of infectious disease testing are the major factors driving the growth of the hepatitis testing market in the Asia Pacific.
Hepatitis Testing Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Hepatitis Testing Market Competitor overview
Some key developments and strategies adopted by manufacturers in the Hepatitis Testing are highlighted below.
· In 2020, Hanwha Chemical merged with Hanwha Q CELLS and Advanced Materials and got renamed as Hanwha Solution.
Hepatitis Testing Market, Key Players
· F.Hoffmann-La Roche Ltd.
· Abbott Laboratories
· Siemens Healthineers AG
· Bio-Rad Laboratories, Inc.
· Danaher Corporation
· QIAGEN
· bioMérieux SA
· DiaSorin S.P.A.
· Ortho Clinical Diagnostics
· MedMira Inc.
· Fujirebio US, Inc.
· Grifols, S.A.
Frequently Asked Questions (FAQ) :
Q1. What is the total CAGR expected to be recorded for the Hepatitis Testing market during the forecast period?
Q2. Which segment is projected to hold the largest share in the Hepatitis Testing Market?
Q3. What are the driving factors for the Hepatitis Testing market?
Q4. Which Segments are covered in the Hepatitis Testing market report?
Q5. Which are the prominent players offering Hepatitis Testing ?
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Hepatitis Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Disease Type
- 5.2.1. Hepatitis B
- 5.2.2. Hepatitis C
- 5.2.3. Other Hepatitis
- 5.3. Market Analysis, Insights and Forecast – By Technology
- 5.3.1. ELISA
- 5.3.2. RDT
- 5.3.3. PCR
- 5.3.4. INAAT
- 5.4. Market Analysis, Insights and Forecast – By End User
- 5.4.1. Hospitals
- 5.4.2. Diagnostic Laboratories
- 5.4.3. Blood Banks
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East, and Africa
6. North America Hepatitis Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Disease Type
- 6.2.1. Hepatitis B
- 6.2.2. Hepatitis C
- 6.2.3. Other Hepatitis
- 6.3. Market Analysis, Insights and Forecast – By Technology
- 6.3.1. ELISA
- 6.3.2. RDT
- 6.3.3. PCR
- 6.3.4. INAAT
- 6.4. Market Analysis, Insights and Forecast – By End User
- 6.4.1. Hospitals
- 6.4.2. Diagnostic Laboratories
- 6.4.3. Blood Banks
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Hepatitis Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Disease Type
- 7.2.1. Hepatitis B
- 7.2.2. Hepatitis C
- 7.2.3. Other Hepatitis
- 7.3. Market Analysis, Insights and Forecast – By Technology
- 7.3.1. ELISA
- 7.3.2. RDT
- 7.3.3. PCR
- 7.3.4. INAAT
- 7.4. Market Analysis, Insights and Forecast – By End User
- 7.4.1. Hospitals
- 7.4.2. Diagnostic Laboratories
- 7.4.3. Blood Banks
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Hepatitis Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Disease Type
- 8.2.1. Hepatitis B
- 8.2.2. Hepatitis C
- 8.2.3. Other Hepatitis
- 8.3. Market Analysis, Insights and Forecast – By Technology
- 8.3.1. ELISA
- 8.3.2. RDT
- 8.3.3. PCR
- 8.3.4. INAAT
- 8.4. Market Analysis, Insights and Forecast – By End User
- 8.4.1. Hospitals
- 8.4.2. Diagnostic Laboratories
- 8.4.3. Blood Banks
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East, and Africa Hepatitis Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Disease Type
- 9.2.1. Hepatitis B
- 9.2.2. Hepatitis C
- 9.2.3. Other Hepatitis
- 9.3. Market Analysis, Insights and Forecast – By Technology
- 9.3.1. ELISA
- 9.3.2. RDT
- 9.3.3. PCR
- 9.3.4. INAAT
- 9.4. Market Analysis, Insights and Forecast – By End User
- 9.4.1. Hospitals
- 9.4.2. Diagnostic Laboratories
- 9.4.3. Blood Banks
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. F.Hoffmann-La Roche Ltd.
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Abbott Laboratories
- 10.6. Siemens Healthineers AG
- 10.7. Bio-Rad Laboratories, Inc.
- 10.8. Danaher Corporation
- 10.9. QIAGEN
- 10.10. bioMérieux SA
- 10.11. DiaSorin S.P.A
- 10.12. Ortho Clinical Diagnostics
- 10.13. MedMira Inc.
- 10.14. Fujirebio US, Inc.
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
